Gore has a 17-year track record in healthcare business management spanning North America, Asia, and Africa
HealthCare Global Enterprises (HCG) has announced the joining of Raj Gore as CEO from February 1, 2021. Gore has a 17-year track record in healthcare business management spanning North America, Asia, and Africa. He has led business transformation and financial turnaround mandates, including post-acquisition integration for acquired healthcare companies in India, Mauritius, and Vietnam. Gore has built high-performance teams and successfully implemented organisation-wide transformation initiatives that have improved employee engagement and patient satisfaction in cross-cultural environments.
Gore joins HCG from Apollo Hospitals, where he was CEO for the Southern Region, responsible for Apollo’s largest region with 15 facilities across Tamil Nadu and Andhra Pradesh. Before Apollo Hospitals, Gore was Chief Growth Officer (India) & Chief Operating Officer – NCR at Fortis Healthcare.
Gore holds a Bachelor of Chemical Engineering degree from Jawaharlal Nehru Engineering College, Maharashtra, Master of Science in Information Technology, and Master of Business Administration degrees from the University of Denver, USA. He has also completed Hospital Management Programs from Indian Institute of Management, Ahmedabad, and Singapore Management University, Singapore.
Dr BS Ajaikumar, former Chairman and CEO, HCG and newly appointed as Executive Chairman, said, “I am delighted to welcome Raj as CEO of HCG. His excellent track record in healthcare and, in particular, his strategic and operational expertise make him the ideal choice to lead our dedicated team and specialized business. HCG is at an inflexion point with the strong turnaround we are seeing across our new centres, and Raj’s experience can help us to strengthen our dominant position in oncology and drive stakeholder value-creation.”
Gore said, “With oncology cases continuing to rise, a comprehensive and focused approach is key to delivering high quality of care and superior outcomes. I look forward to building on HCG’s legacy as the most trusted brand in oncology, sustained by a relentless focus on patient outcomes and research-driven treatment and care.”
Amit Soni, Managing Director of CVC and Board member, HCG, added, “We are excited about Gore joining as CEO. HCG has created a differentiated model to provide access to high-quality oncology care across the country, at scale, demonstrating great resilience during COVID. Now with the completion of our capex cycle, a strong balance sheet, and with a seasoned professional such as Gore on board, we look forward to an exciting phase of clinical, operational and financial efficiencies across the organization, working to deliver HCG’s vision of excellence in oncology.”